237 related articles for article (PubMed ID: 26439188)
1. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
Kim EM; Manzar G; Zavazava N
Immunology; 2017 Jun; 151(2):191-197. PubMed ID: 28185259
[TBL] [Abstract][Full Text] [Related]
4. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
5. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
[TBL] [Abstract][Full Text] [Related]
6. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
7. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.
Liu X; Li W; Fu X; Xu Y
Front Immunol; 2017; 8():645. PubMed ID: 28626459
[TBL] [Abstract][Full Text] [Related]
8. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
9. Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain.
Gao M; Yao H; Dong Q; Zhang H; Yang Z; Yang Y; Zhu J; Xu M; Xu R
Sci Rep; 2016 Jul; 6():29955. PubMed ID: 27417157
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
[TBL] [Abstract][Full Text] [Related]
11. Immunological Issues After Stem Cell-Based β Cell Replacement.
Sordi V; Pellegrini S; Piemonti L
Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
[TBL] [Abstract][Full Text] [Related]
12. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.
Zhao T; Zhang ZN; Westenskow PD; Todorova D; Hu Z; Lin T; Rong Z; Kim J; He J; Wang M; Clegg DO; Yang YG; Zhang K; Friedlander M; Xu Y
Cell Stem Cell; 2015 Sep; 17(3):353-9. PubMed ID: 26299572
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
14. iPSCs, aging and age-related diseases.
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
[TBL] [Abstract][Full Text] [Related]
15. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
Scheiner ZS; Talib S; Feigal EG
J Biol Chem; 2014 Feb; 289(8):4571-7. PubMed ID: 24362036
[TBL] [Abstract][Full Text] [Related]
16. Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy.
Chhabra A
Front Immunol; 2017; 8():993. PubMed ID: 28868053
[TBL] [Abstract][Full Text] [Related]
17. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
[TBL] [Abstract][Full Text] [Related]
18. Human Dendritic Cell-Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic.
Chhabra A; Chen IP; Batra D
J Immunol; 2017 Mar; 198(5):1875-1886. PubMed ID: 28115528
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
20. Neural progenitor cells from human induced pluripotent stem cells generated less autogenous immune response.
Huang K; Liu P; Li X; Chen S; Wang L; Qin L; Su Z; Huang W; Liu J; Jia B; Liu J; Cai J; Pei D; Pan G
Sci China Life Sci; 2014 Feb; 57(2):162-70. PubMed ID: 24443177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]